Enjoy complimentary customisation on priority with our Enterprise License!
The insulin pens market share is expected to increase by USD 3.43 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 8%.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (reusable insulin pens and disposable insulin pens) and geography (North America, Europe, Asia, and ROW).
The insulin pens market report also offers information on several market vendors, including Becton, Dickinson and Co., Biocon Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Innovation Zed Ltd., Medtronic Plc, Nemera, Novo Nordisk AS, Owen Mumford Ltd., and Sanofi SA among others.
Becton, Dickinson and Co. - The company offers insulin pens such as BD Pen Needles and Insulin Syringes. The BD Medical segment offers a range of medication delivery solutions, medication management solutions, diabetes care, and pharmaceutical systems.
Get the Insulin Pens Market Size Forecast by Downloading the Report Sample
Technavio categorizes the global insulin pens market as a part of the global healthcare equipment market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Insulin Pens Market Driver
Key Insulin Pens Market Challenge
This insulin pens market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Our In-house experts produce extensive information on the value chain and parent market of the market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions by Requesting a PDF Sample now!
36% of the market’s growth will originate from North America during the forecast period. the US is the key market for insulin pens in North America. Market growth in this region will be faster than the growth of the market in ROW regions.
The insulin pens market in North America is expected to grow at a moderate rate. This is due to the presence of the US and Canada which are the significant revenue contributors in the region. The presence of key vendors in the global insulin pens market in North America has also been driving market growth in the region. Eli Lilly and BD have their headquarters in the US. This will facilitate the insulin pens market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain insights on the market contribution of various segments Request a PDF Sample
The insulin pens market share growth by the reusable insulin pens segment will be significant during the forecast period. Reusable pens are globally used by patients with diabetes. A reusable insulin pen contains a replaceable insulin cartridge, which can be used multiple times by just replacing the insulin cartridge. The reusability of these devices makes them cost-effective. Furthermore, reusable pens such as NovoPen 4 are significantly easier to use compared with other pens. Also, they have many useful features. For instance, these pens prevent the user from dialling up more insulin than is left in the cartridge, which eliminates the need to inject twice for one dose when an insulin cartridge is running out.
This report provides an accurate prediction of the contribution of all the segments to the growth of the insulin pens market size and actionable market insights on the post-COVID-19 impact on each segment.
Insulin Pens Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8% |
Market growth 2021-2025 |
$ 3.43 billion |
Market structure |
Concentrated |
YoY growth (%) |
7.78 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 36% |
Key countries |
US, Germany, France, and China |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Becton, Dickinson and Co., Biocon Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Innovation Zed Ltd., Medtronic Plc, Nemera, Novo Nordisk AS, Owen Mumford Ltd., and Sanofi SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer Landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.